Important note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
 |
U.S. Department of Health and Human Services; National Institutes Of Health; National Institute of Allergy and Infectious Diseases (NIAID) - NIAID Online Update - March 20, 2008
WHAT:
On Tuesday, March 25, 2008, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, will host an HIV Vaccine Summit in Bethesda, Md. as an important step in the ongoing process to examine the current direction of HIV vaccine research. Through an interactive panel discussions, NIAID and the scientific and HIV advocacy communities will explore:
Based on the panel discussions, NIAID is seeking specific recommendations on the types of research to foster and how to attract novel vaccine research ideas.
Registration to attend the meeting in-person has closed. However, NIAID invites interested parties to watch the summit live via Webcast.
WHEN:
Tuesday, March 25, 2008
8:30 a.m. to 4:45 p.m. EST
WHERE:
To view the online NIAID HIV Vaccine Summit Webcast, go to: http://hivsummit.dgimeetingsupport.com. The "View Webcast" link will be live on March 25.
NIAID welcomes any ongoing comments or questions concerning its HIV vaccine research and development activities at HIVVaccineSummit@niaid.nih.gov.
CONTACT:
For more information, contact the NIAID Office of Communications at
(301) 402-1663, niaidnews@niaid.nih.gov.
NIAID is a component of the National Institutes of Health. NIAID supports basic and applied research to prevent, diagnose and treat infectious diseases such as HIV/AIDS and other sexually transmitted infections, influenza, tuberculosis, malaria and illness from potential agents of bioterrorism. NIAID also supports research on basic immunology, transplantation and immune-related disorders, including autoimmune diseases, asthma and allergies.
The National Institutes of Health (NIH)--The Nation's Medical Research Agency--includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.
080320
NI080304
Published 2008 - National Institute of Allergy and Infectious Diseases . All material contained in this report is in the public domain and may be used and reprinted without special permission; citation to source, however, is appreciated.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .